Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Ulrich Schäfer Added: 3 years ago
As the field of interventional cardiology has grown, so too has interest in mitigating severe adverse outcomes such as stroke. Unfortunately, the risk of stroke is increased by many underlying disease conditions (atrial fibrillation, patent foramen ovale, carotid artery disease and other vascular disease affecting brain perfusion, etc.), making clear differentiation between cardiac intervention… View more

Prevention & Chronic Conditions

Intervention
Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
Author(s): Antonio Greco , Davide Capodanno Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) is a valuable treatment option for patients with severe symptomatic aortic stenosis.1 Its use is supported by the results of multiple randomised controlled trials (RCTs) exploring the entire surgical risk spectrum, including inoperable, high-risk, intermediate risk and low risk patients.2–8 TAVI is associated with a small but not negligible… View more

Vascular Disease and Surgery

Intervention
Managing Stroke During Transcatheter Aortic Valve Replacement
Author(s): Florian Hecker , Mani Arsalan , Thomas Walther Added: 3 years ago
Transcatheter aortic valve replacement (TAVR) has become the default treatment option for high-risk patients with aortic stenosis (AS) and, based on heart team discussion, an alternative to surgical aortic valve replacement (SAVR) in intermediate-risk patients. TAVR has led to a paradigm shift in the basic therapeutic principle to treat AS: calcifications, in some patients quite excessive, are… View more

Vascular Disease and Surgery

Intervention
Chimney Stenting During Transcatheter Aortic Valve Implantation
Author(s): Liesbeth Rosseel , Michael Rosseel , Brian G Hynes , et al Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) has emerged as a safe and effective strategy for the treatment of symptomatic and severe aortic valve stenosis (AS).1 The choice between a transcatheter or surgical approach is no longer dependant on the estimated surgical risk, but rather the institutional heart team’s assessment of medical comorbid illnesses and frailty, individual cardiac and… View more

Vascular Disease and Surgery

Intervention
Author(s): Raquel del Valle-Fernández , Carlos E Ruiz Added: 3 years ago
The foramen ovale provides communication between both atria in utero, and although anatomical closure usually occurs in the first two years of life, it may remain patent (patent foramen ovale [PFO]) into adulthood. The autopsy prevalence of PFO was 27% among 965 otherwise normal hearts,1 and transoesophageal echocardiography detected PFO in 24.3% of 585 randomly sampled individuals.2 PFO is… View more

Intervention

Heterogeneous Populations
Antithrombotic Therapy in AF-PCI Patients
Author(s): Antonio Greco , Claudio Laudani , Carla Rochira , et al Added: 1 year ago

Anticoagulation

Intervention
Author(s): John A Kaufman Added: 3 years ago
Optional vena cava (VC) filters are filtration devices that can be placed percutaneously into the inferior VC (IVC) to provide protection from pulmonary embolism (PE). These devices can be either removed (retrievable filters) or altered in some way to no longer function as a filter while remaining in the IVC (convertible filters), although the latter are not yet commercially available. The… View more

Standards & Guidelines

Intervention
Author(s): Jennifer Franke , Nina Wunderlich , Horst Sievert Added: 3 years ago
As an intra-cardiac right-to-left shunt, the patent foramen ovale (PFO) has gained attention over the last two decades because of its potential pathological importance in a number of disease processes including stroke, peripheral embolism, systemic oxygen desaturation (i.e. hypoxaemia) and migraine headaches. Percutaneous PFO closure, using a double-umbrella Clamshell device (Bard, USCI,… View more

Prevention & Chronic Conditions
Author(s): Apostolos Tzikas , Darren Mylotte , Martin Bergmann Added: 3 years ago
Atrial fibrillation (AF), the most common arrhythmia, is associated with a significantly increased risk of morbidity and mortality due to a fivefold increase in the frequency of thromboembolic stroke.1 The gold standard treatment for the prevention of AF-related thromboembolism is oral anticoagulation (OAC), based on an individualised patient risk assessment with either the CHADS2 or the CHA2DS2… View more

Electrophysiology & Arrhythmia

Prevention & Chronic Conditions
Peripartum CS and MCS
Author(s): Giulia Botti , Sharmaine Thirunavukarasu , Francesca Ziviello , et al Added: 4 months ago

Heart Failure

Prevention & Chronic Conditions